Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZURA Zura Bio

盘后交易 03-18 16:45:42 EDT

5.99

-0.45

-6.99%

盘后5.99

+0.000.00%

16:10 EDT

最高6.58	最低5.90	成交量58.82万
今开6.44	昨收6.44	日振幅10.56%
总市值5.63亿	流通市值2.87亿	总股本9,391万
成交额361.49万	换手率1.23%	流通股本4,793万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":5.99,"timestamp":1773864000000,"preClose":6.44,"halted":0,"volume":588183,"hourTrading":{"tag":"盘后","latestPrice":5.99,"preClose":5.99,"latestTime":"16:10 EDT","volume":2645,"amount":15843.550000000001,"timestamp":1773864605131,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06987577639751555,"floatShares":47926899,"shares":93906700,"eps":-0.670864,"marketStatus":"盘后交易","change":-0.45,"latestTime":"03-18 16:45:42 EDT","open":6.44,"high":6.58,"low":5.9,"amount":3614919.369802,"amplitude":0.10559,"askPrice":6.31,"askSize":606,"bidPrice":5.61,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.670864,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":6.44,"preHourTrading":{"tag":"盘前","latestPrice":6.67,"preClose":6.44,"latestTime":"08:40 EDT","volume":75,"amount":500.25,"timestamp":1773837639365,"change":0.23,"changeRate":0.035714,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.99,"preClose":5.99,"latestTime":"16:10 EDT","volume":2645,"amount":15843.550000000001,"timestamp":1773864605131,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.448712,"impliedVol":0.8839,"impliedVolPercentile":0.2311},"requestUrl":"/m/hq/s/ZURA","defaultTab":"news","newsList":[{"id":"2617520117","title":"Zura Bio Limited盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617520117?lang=zh_cn&edition=full","pubTime":"2026-03-05 23:31","pubTimestamp":1772724688,"startTime":"0","endTime":"0","summary":"北京时间2026年03月05日23时31分，Zura Bio Limited股票出现波动，股价快速下跌5.29%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为1.66%。其相关个股中，Impact Biomedical, Inc.、Tenaya Therapeutics, Inc.、Quince Therapeutics, Inc.涨幅较大，Quince Therapeutics, Inc.、Impact Biomedical, Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为331.89%、144.87%、47.23%，振幅较大的相关个股有Impact Biomedical, Inc.、Tenaya Therapeutics, Inc.、Osr Holdings, Inc.，振幅分别为37.84%、33.32%、27.56%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305233128a6a74d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305233128a6a74d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"1146723543","title":"Zura Bio完成1.44亿美元公开发行 承销商超额配售权全额行使","url":"https://stock-news.laohu8.com/highlight/detail?id=1146723543","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146723543?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:31","pubTimestamp":1772191877,"startTime":"0","endTime":"0","summary":"生物技术公司Zura Bio近日宣布，其总额达1.44亿美元的公开募股已正式完成。此次发行中，承销商全额行使了额外购股选择权，显示出市场对该公司发展前景的强烈信心。这笔资金的注入将为Zura Bio推进其创新疗法研发提供重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"1189932141","title":"Zura Bio迎来药物研发领域资深专家Mark Eisner博士与Ajay Nirula博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1189932141","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189932141?lang=zh_cn&edition=full","pubTime":"2026-02-23 19:31","pubTimestamp":1771846277,"startTime":"0","endTime":"0","summary":"生物制药企业Zura Bio近日宣布，两位在药物开发领域拥有深厚资历的专家——Mark Eisner博士（同时拥有公共卫生硕士学位）与Ajay Nirula博士（拥有医学及哲学双博士学位）正式加入公司董事会。这一重要人事任命将显著增强公司在临床开发与科学战略方面的领导力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2609137703","title":"Zura Bio Limited盘中异动 早盘股价大跌5.06%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609137703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609137703?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:15","pubTimestamp":1770218110,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时15分，Zura Bio Limited股票出现异动，股价急速下挫5.06%。截至发稿，该股报6.00美元/股，成交量4.0016万股，换手率0.06%，振幅5.66%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.65%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231510a47c7061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204231510a47c7061&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2604910646","title":"Zura Bio Limited盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604910646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604910646?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:31","pubTimestamp":1768573905,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时31分，Zura Bio Limited股票出现异动，股价急速上涨5.12%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Jaguar Health, Inc.、Immunitybio, Inc.、Kala Bio, Inc.涨幅较大，Jaguar Health, Inc.、Biodexa Pharmaceuticals Plc、Genprex, Inc.较为活跃，换手率分别为766.70%、105.18%、8.90%，振幅较大的相关个股有Jaguar Health, Inc.、Immunitybio, Inc.、Iterum Therapeutics Plc，振幅分别为24.85%、8.86%、8.66%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223145a7236468&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223145a7236468&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"1178014392","title":"Zura Bio有限公司于12月29日签署多项协议，SEC文件确认其商业优势显著提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1178014392","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178014392?lang=zh_cn&edition=full","pubTime":"2026-01-03 05:29","pubTimestamp":1767389350,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会文件披露，Zura Bio有限公司在12月29日与多个合作单元达成系列战略性协议。经专业评估，这些协议被确认将为公司创造更优越的商业价值与市场竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2593423227","title":"Zura Bio Limited盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593423227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593423227?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:38","pubTimestamp":1766500697,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时38分，Zura Bio Limited股票出现波动，股价急速跳水5.06%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.14%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223817a46f5d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223817a46f5d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2592911629","title":"Zura Bio Limited盘中异动 早盘快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592911629?lang=zh_cn&edition=full","pubTime":"2025-12-17 23:05","pubTimestamp":1765983952,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日23时05分，Zura Bio Limited股票出现波动，股价大幅上涨5.10%。截至发稿，该股报4.33美元/股，成交量4.3007万股，换手率0.07%，振幅5.10%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.28%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217230553953b651f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217230553953b651f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2588270351","title":"Zura Bio Limited盘中异动 快速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588270351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588270351?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:34","pubTimestamp":1764599645,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时34分，Zura Bio Limited股票出现异动，股价快速下挫5.69%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Q32 Bio Inc.、Kala Bio, Inc.、Maia Biotechnology, Inc.涨幅较大，Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃，换手率分别为510.54%、507.40%、48.28%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Kala Bio, Inc.，振幅分别为101.36%、31.05%、18.63%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012234059524dbbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012234059524dbbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2584523869","title":"Zura Bio Limited盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584523869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584523869?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:57","pubTimestamp":1763477878,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时57分，Zura Bio Limited股票出现异动，股价快速下跌5.26%。截至发稿，该股报3.78美元/股，成交量3.2416万股，换手率0.05%，振幅2.76%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.35%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118225759a4aa917e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118225759a4aa917e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"1114353463","title":"Zura Bio有限公司：预计现有现金及现金等价物足以支持到2027年的计划运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1114353463","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114353463?lang=zh_cn&edition=full","pubTime":"2025-11-13 19:38","pubTimestamp":1763033896,"startTime":"0","endTime":"0","summary":"Zura Bio有限公司：预计现有现金及现金等价物足以支持到2027年的计划运营","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2583367539","title":"Zura Bio Limited盘中异动 股价大涨5.20%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583367539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583367539?lang=zh_cn&edition=full","pubTime":"2025-11-13 04:53","pubTimestamp":1762980781,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日04时53分，Zura Bio Limited股票出现波动，股价大幅拉升5.20%。截至发稿，该股报4.65美元/股，成交量69.5972万股，换手率1.07%，振幅9.05%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.42%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304530195009a9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304530195009a9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2582165361","title":"Zura Bio Limited盘中异动 股价大涨5.31%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582165361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582165361?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:07","pubTimestamp":1762794439,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日01时07分，Zura Bio Limited股票出现异动，股价快速拉升5.31%。截至发稿，该股报3.87美元/股，成交量9.8894万股，换手率0.15%，振幅4.63%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.51%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111010719a6eff731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111010719a6eff731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2574488368","title":"Zura Bio Limited盘中异动 早盘快速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574488368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574488368?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:36","pubTimestamp":1760107013,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时36分，Zura Bio Limited股票出现波动，股价急速下挫5.17%。截至发稿，该股报4.28美元/股，成交量34.1644万股，换手率0.53%，振幅6.43%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.35%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102236539726b3a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102236539726b3a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2518275139","title":"Zura Bio Limited盘中异动 急速跳水5.56%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275139?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:06","pubTimestamp":1741615597,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时06分，Zura Bio Limited股票出现异动，股价大幅下跌5.56%。截至发稿，该股报1.19美元/股，成交量1.1839万股，换手率0.02%，振幅6.35%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.00%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220637abf309bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220637abf309bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2517943131","title":"Zura Bio Limited盘中异动 早盘股价大涨5.22%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943131?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:00","pubTimestamp":1741186837,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时00分，Zura Bio Limited股票出现波动，股价急速上涨5.22%。截至发稿，该股报1.21美元/股，成交量2.0808万股，换手率0.03%，振幅5.61%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.27%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230037a260d154&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230037a260d154&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2516839670","title":"Zura Bio Limited盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516839670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516839670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:40","pubTimestamp":1741099251,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时40分，Zura Bio Limited股票出现异动，股价大幅下跌5.56%。截至发稿，该股报1.11美元/股，成交量1.578万股，换手率0.02%，振幅8.78%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.13%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224052989baeed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224052989baeed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2516632966","title":"Zura Bio Limited盘中异动 股价大涨6.58%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632966?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012387,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Zura Bio Limited股票出现异动，股价急速拉升6.58%。截至发稿，该股报1.45美元/股，成交量4.3512万股，换手率0.07%，振幅3.86%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.21%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223307a25d4037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223307a25d4037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2514376511","title":"Zura Bio Limited盘中异动 快速拉升5.83%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376511?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:38","pubTimestamp":1740757132,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时38分，Zura Bio Limited股票出现波动，股价快速拉升5.83%。截至发稿，该股报1.27美元/股，成交量2.5359万股，换手率0.04%，振幅7.50%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.24%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823385296342938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823385296342938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2514901334","title":"Zura Bio Limited盘中异动 早盘快速跳水5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514901334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514901334?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494663,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Zura Bio Limited股票出现波动，股价快速下挫5.26%。截至发稿，该股报1.26美元/股，成交量12.0645万股，换手率0.18%，振幅7.52%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.37%。Zura Bio Limited公司简介：Zura Bio Ltd是一家多资产临床阶段生物技术公司，专注于开发免疫和炎症性疾病的新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424962ff595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424962ff595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zurabio.com","stockEarnings":[{"period":"1week","weight":-0.0667},{"period":"1month","weight":0.0592},{"period":"3month","weight":0.5047},{"period":"6month","weight":2.1415},{"period":"1year","weight":3.7353},{"period":"ytd","weight":0.229}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zura Bio Limited成立于2022年1月。该公司是一家临床阶段、多资产免疫学公司，致力于为一系列未满足需求的自身免疫和炎症性疾病开发新型双通路抗体。凭借团队的丰富经验，公司识别相关疾病，并在这些疾病中开发差异化资产。公司战略重点是利用双通路生物的力量，为自身免疫性和炎症性疾病患者提供更广泛、更深层次的临床获益。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.109805},{"month":2,"riseRate":0.8,"avgChangeRate":0.039352},{"month":3,"riseRate":0.4,"avgChangeRate":0.01071},{"month":4,"riseRate":0.75,"avgChangeRate":0.079189},{"month":5,"riseRate":0.25,"avgChangeRate":-0.072869},{"month":6,"riseRate":0.75,"avgChangeRate":0.041052},{"month":7,"riseRate":0.75,"avgChangeRate":0.075734},{"month":8,"riseRate":0.75,"avgChangeRate":0.126932},{"month":9,"riseRate":0.5,"avgChangeRate":0.266974},{"month":10,"riseRate":0.6,"avgChangeRate":-0.062262},{"month":11,"riseRate":0.6,"avgChangeRate":-0.053189},{"month":12,"riseRate":0.4,"avgChangeRate":0.029811}],"exchange":"NASDAQ","name":"Zura Bio","nameEN":"Zura Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zura Bio(ZURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zura Bio,ZURA,Zura Bio股票,Zura Bio股票老虎,Zura Bio股票老虎国际,Zura Bio行情,Zura Bio股票行情,Zura Bio股价,Zura Bio股市,Zura Bio股票价格,Zura Bio股票交易,Zura Bio股票购买,Zura Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zura Bio(ZURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}